OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Join Zoom Meeting:
aarhusuniversity.zoom.us/j/69899934764
Meeting ID: 698 9993 4764
Abstract
Renal replacement therapy (RRT) is a treatment commonly used for managing critically ill patients with severe acute kidney injury (AKI), particularly those experiencing metabolic or fluid-related complications. RRT may rapidly correct some of the life-threatening issues associated with AKI, such as fluid overload. However, it is a very invasive treatment and may therefore be harmful to some patients. The timing of RRT initiation in critically ill patients with AKI remains a long-standing dilemma for nephrologists. Multiple randomized trials have attempted to address this question, but they compare only a limited number of treatment initiation strategies. In light of this, we use routinely collected observational data from the Ghent University Hospital intensive care units to investigate treatment strategies for starting RRT in critically ill AKI patients. We develop a methodology for identifying the optimal treatment initiation strategy from several pre-specified options in the presence of competing risks. We then apply it to evaluate a total of 81 RRT initiation strategies, expressed in terms of serum potassium, pH, and urine output, allowing us to identify the optimal thresholds for these criteria. Furthermore, we develop a general framework of weighted Neyman-orthogonal learners for estimating heterogeneous treatment effects to support clinical decision-making regarding treatment initiation.
Bio: I am an assistant professor of biostatistics in the Department of Public Health at the University of Copenhagen. My research centers on causal and statistical inference, with a particular focus on infinite-dimensional parameters and their applications to the study of common complex diseases.
